ArticleNature communications2025
Crafting defects in two-dimensional organic platelets via seeded coassembly enables emergent molecular recognition.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Defect engineering plays a pivotal role in materials science, as defects significantly influence material properties. However, achieving precise control over defects in pure organic systems remains a challenge. In this study, we demonstrate the creation of controllable defects in molecular crystals through supersaturated solution-fed seeded self-assembly of two strategically designed molecules. One molecule features 2-(2'-hydroxyphenyl)benzimidazole groups at both ends, enabling the formation of an intramolecular hydrogen bond on one side while leaving the hydrogen bond donors on the other side available for potential intermolecular interactions. When coassembled with a second molecule containing benzimidazole groups capable of continuous intermolecular hydrogen bonding, defects in the hydrogen-bonding network are introduced, resulting in the formation of defects within the resulting two-dimensional cocrystals. The defect density can be precisely tuned by adjusting the molar ratio of the two molecules. Remarkably, these defects exhibit shape-complementary hydrogen bonding with dimethoate enabling high sensitivity and selectivity molecular recognition.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.